Bumrungrad Hospital Public Company Limited (BUHPF) Stock

About Bumrungrad Hospital Public Company Limited

Bumrungrad Hospital Public Company Limited, headquartered in Bangkok, Thailand, and established in 1980, operates as a prominent healthcare provider both within Thailand and across international borders. Its primary medical facility provides a comprehensive range of diagnostic, therapeutic, and critical care services. An extensive network of approximately 56 specialized outpatient clinics and centers covers a diverse array of medical disciplines, including but not limited to allergy treatment, dental care, cardiology, oncology, orthopedics, women's health, and various specialized areas like fertility, neurosciences, and sports medicine. Beyond direct patient care, Bumrungrad also engages in real estate investment, conducts clinical research, distributes pharmaceuticals and medical supplies through dedicated retail outlets, runs a training center for healthcare professionals, and provides patient referral services. The facility operates with a capacity of 580 beds.

Bumrungrad Hospital Public Company Limited is headquartered in TH.

Bumrungrad Hospital Public Company Limited (BUHPF) stock trades at $5.45 with a market capitalization of $4.33B. The stock is valued at a price-to-earnings (P/E) ratio of 19.80, price-to-book of 4.63, price-to-sales of 5.93. Over the past 52 weeks the stock has ranged between $4.85 and $5.65, and currently trades 3.5% below its 52-week high. It pays a dividend yielding 10.09%.

On profitability, Bumrungrad Hospital Public Company Limited generates a return on equity (ROE) of 25.10% — well above the market average, a sign of a high-quality business, return on capital employed of 25.78%, an operating margin of 34.93%, a net profit margin of 29.96%.

Official website: www.bumrungrad.com